Novavax is a clinical stage vaccine developer who has been at the forefront of vaccine technology since it was founded in 1987. Based in Geithersburg, Maryland, in the US, Novavax specialises in the development and production of recombinant protein nanoparticles to produce vaccines and virus like particles (VPLs) and recombinant protein micelles. Next Page >

April 30, 2014 The University of Maryland School of Medicine (UM SOM) and Novavax, Inc. today announced that an investigational vaccine candidate developed by Novavax against the recently emerged Middle East Respiratory Syndrome Coronavirus (MERS-CoV) blocked infection in laboratory studies. UM SOM and Novavax also reported that a vaccine candidate against Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) developed by Novavax …

Vaccine candidate was well-tolerated with no vaccine-related serious adverse events Highest immune responses observed with a single dose of vaccine combined with aluminum phosphate adjuvant Women with the lowest baseline levels of RSV neutralizing antibodies had the largest increases following immunization, consistent with prior data Palivizumab-like antibodies exceeded levels observed in previous trials High levels of antibodies developed within 14 days after …

April 7, 2014 Novavax, Inc., a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of recombinant nanoparticle vaccines and adjuvants, today announced the appointment of Cynthia N. Oliver, Ph.D. to the position of Senior Vice President, Process Development Operations, effective April 8, 2014. Dr. Oliver will be responsible for all process development activities, with a specific focus on …

In space, hydrogen from a companion star can build up on the surface of an adjacent white dwarf star. This hydrogen then ignites in a cataclysmic thermonuclear explosion, emitting a huge burst of light – the transformation into a super-bright star called a nova. Is it any coincidence, then, that both Novartis and Novavax have simultaneously announced some shining results …